Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CreaVax-HCC by JW CreaGene for Hepatocellular Carcinoma: Likelihood of Approval
CreaVax-HCC is under clinical development by JW CreaGene and currently in Phase III for Hepatocellular Carcinoma. According to GlobalData, Phase...